218 related articles for article (PubMed ID: 26031333)
21. Multisite phosphorylation of adipocyte and hepatocyte phosphodiesterase 3B.
Lindh R; Ahmad F; Resjö S; James P; Yang JS; Fales HM; Manganiello V; Degerman E
Biochim Biophys Acta; 2007 Apr; 1773(4):584-92. PubMed ID: 17320989
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of cyclic-nucleotide phosphodiesterase 3B in 3T3-L1 adipocytes induced by tumour necrosis factor alpha and cAMP.
Rahn Landström T; Mei J; Karlsson M; Manganiello V; Degerman E
Biochem J; 2000 Mar; 346 Pt 2(Pt 2):337-43. PubMed ID: 10677351
[TBL] [Abstract][Full Text] [Related]
23. Phorbol 12-myristate 13-acetate inhibits the antilipolytic action of insulin, probably via the activity of protein kinase Cε.
Nakamura J
Eur J Pharmacol; 2010 Dec; 648(1-3):188-94. PubMed ID: 20826143
[TBL] [Abstract][Full Text] [Related]
24. Identification of the insulin-regulated interaction of phosphodiesterase 3B with 14-3-3 beta protein.
Onuma H; Osawa H; Yamada K; Ogura T; Tanabe F; Granner DK; Makino H
Diabetes; 2002 Dec; 51(12):3362-7. PubMed ID: 12453887
[TBL] [Abstract][Full Text] [Related]
25. Hypothalamic Phosphodiesterase 3B Pathway Mediates Anorectic and Body Weight-Reducing Effects of Insulin in Male Mice.
Sahu M; Anamthathmakula P; Sahu A
Neuroendocrinology; 2017; 104(2):145-156. PubMed ID: 27002827
[TBL] [Abstract][Full Text] [Related]
26. Inactivation of NF-κB p65 (RelA) in Liver Improves Insulin Sensitivity and Inhibits cAMP/PKA Pathway.
Ke B; Zhao Z; Ye X; Gao Z; Manganiello V; Wu B; Ye J
Diabetes; 2015 Oct; 64(10):3355-62. PubMed ID: 26038580
[TBL] [Abstract][Full Text] [Related]
27. Long-term regulation of cyclic nucleotide phosphodiesterase type 3B and 4 in 3T3-L1 adipocytes.
Oknianska A; Zmuda-Trzebiatowska E; Manganiello V; Degerman E
Biochem Biophys Res Commun; 2007 Feb; 353(4):1080-5. PubMed ID: 17198676
[TBL] [Abstract][Full Text] [Related]
28. Plasma membrane cyclic nucleotide phosphodiesterase 3B (PDE3B) is associated with caveolae in primary adipocytes.
Nilsson R; Ahmad F; Swärd K; Andersson U; Weston M; Manganiello V; Degerman E
Cell Signal; 2006 Oct; 18(10):1713-21. PubMed ID: 16503395
[TBL] [Abstract][Full Text] [Related]
29. From PDE3B to the regulation of energy homeostasis.
Degerman E; Ahmad F; Chung YW; Guirguis E; Omar B; Stenson L; Manganiello V
Curr Opin Pharmacol; 2011 Dec; 11(6):676-82. PubMed ID: 22001403
[TBL] [Abstract][Full Text] [Related]
30. White to beige conversion in PDE3B KO adipose tissue through activation of AMPK signaling and mitochondrial function.
Chung YW; Ahmad F; Tang Y; Hockman SC; Kee HJ; Berger K; Guirguis E; Choi YH; Schimel DM; Aponte AM; Park S; Degerman E; Manganiello VC
Sci Rep; 2017 Jan; 7():40445. PubMed ID: 28084425
[TBL] [Abstract][Full Text] [Related]
31. Insulin and β-adrenergic receptors mediate lipolytic and anti-lipolytic signalling that is not altered by type 2 diabetes in human adipocytes.
Jönsson C; Castor Batista AP; Kjølhede P; Strålfors P
Biochem J; 2019 Oct; 476(19):2883-2908. PubMed ID: 31519735
[TBL] [Abstract][Full Text] [Related]
32. The role of mouse Akt2 in insulin-dependent suppression of adipocyte lipolysis in vivo.
Koren S; DiPilato LM; Emmett MJ; Shearin AL; Chu Q; Monks B; Birnbaum MJ
Diabetologia; 2015 May; 58(5):1063-70. PubMed ID: 25740694
[TBL] [Abstract][Full Text] [Related]
33. RNA-binding protein CUGBP1 regulates insulin secretion via activation of phosphodiesterase 3B in mice.
Zhai K; Gu L; Yang Z; Mao Y; Jin M; Chang Y; Yuan Q; Leblais V; Wang H; Fischmeister R; Ji G
Diabetologia; 2016 Sep; 59(9):1959-67. PubMed ID: 27255754
[TBL] [Abstract][Full Text] [Related]
34. cUMP hydrolysis by PDE3B.
Ostermeyer J; Golly F; Kaever V; Dove S; Seifert R; Schneider EH
Naunyn Schmiedebergs Arch Pharmacol; 2018 Sep; 391(9):891-905. PubMed ID: 29808231
[TBL] [Abstract][Full Text] [Related]
35. Thiazolidinediones attenuate lipolysis and ameliorate dexamethasone-induced insulin resistance.
He J; Xu C; Kuang J; Liu Q; Jiang H; Mo L; Geng B; Xu G
Metabolism; 2015 Jul; 64(7):826-36. PubMed ID: 25825274
[TBL] [Abstract][Full Text] [Related]
36. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
Elks ML; Manganiello VC
Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
[TBL] [Abstract][Full Text] [Related]
37. Apelin inhibits insulin secretion in pancreatic beta-cells by activation of PI3-kinase-phosphodiesterase 3B.
Guo L; Li Q; Wang W; Yu P; Pan H; Li P; Sun Y; Zhang J
Endocr Res; 2009; 34(4):142-54. PubMed ID: 19878074
[TBL] [Abstract][Full Text] [Related]
38. Phosphatidylinositol 3-kinase is an upstream regulator of the phosphodiesterase 3B pathway of leptin signalling that may not involve activation of Akt in the rat hypothalamus.
Sahu A; Koshinaka K; Sahu M
J Neuroendocrinol; 2013 Feb; 25(2):168-79. PubMed ID: 22967108
[TBL] [Abstract][Full Text] [Related]
39. Importance of cAMP-response element-binding protein in regulation of expression of the murine cyclic nucleotide phosphodiesterase 3B (Pde3b) gene in differentiating 3T3-L1 preadipocytes.
Liu H; Tang JR; Choi YH; Napolitano M; Hockman S; Taira M; Degerman E; Manganiello VC
J Biol Chem; 2006 Jul; 281(30):21096-21113. PubMed ID: 16702214
[TBL] [Abstract][Full Text] [Related]
40. A newly identified 50 kDa protein, which is associated with phosphodiesterase 3B, is phosphorylated by insulin in rat adipocytes.
Onuma H; Osawa H; Ogura T; Tanabe F; Nishida W; Makino H
Biochem Biophys Res Commun; 2005 Nov; 337(3):976-82. PubMed ID: 16225849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
